- Home
- CDNA vs GILT Comparison
CDNA vs GILT Comparison
Compare CDNA & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- GILT
- Stock Information
- Founded
- CDNA 1998
- GILT 1987
- Country
- CDNA United States
- GILT Israel
- Employees
- CDNA N/A
- GILT N/A
- Industry
- CDNA Medical Specialities
- GILT Radio And Television Broadcasting And Communications Equipment
- Sector
- CDNA Health Care
- GILT Technology
- Exchange
- CDNA Nasdaq
- GILT Nasdaq
- Market Cap
- CDNA 712.2M
- GILT 756.1M
- IPO Year
- CDNA 2014
- GILT 1993
- Fundamental
- Price
- CDNA $18.03
- GILT $11.27
- Analyst Decision
- CDNA Buy
- GILT Strong Buy
- Analyst Count
- CDNA 7
- GILT 1
- Target Price
- CDNA $26.00
- GILT $16.00
- AVG Volume (30 Days)
- CDNA 1.2M
- GILT 822.3K
- Earning Date
- CDNA 11-04-2025
- GILT 11-12-2025
- Dividend Yield
- CDNA N/A
- GILT N/A
- EPS Growth
- CDNA N/A
- GILT 42.22
- EPS
- CDNA 1.22
- GILT 0.41
- Revenue
- CDNA $357,998,000.00
- GILT $392,826,000.00
- Revenue This Year
- CDNA $12.73
- GILT $47.18
- Revenue Next Year
- CDNA $11.90
- GILT $13.80
- P/E Ratio
- CDNA $14.75
- GILT $26.34
- Revenue Growth
- CDNA 14.46
- GILT 29.68
- 52 Week Low
- CDNA $10.96
- GILT $5.26
- 52 Week High
- CDNA $26.37
- GILT $15.24
- Technical
- Relative Strength Index (RSI)
- CDNA 67.03
- GILT 37.70
- Support Level
- CDNA $15.60
- GILT $10.42
- Resistance Level
- CDNA $17.09
- GILT $11.68
- Average True Range (ATR)
- CDNA 1.02
- GILT 0.62
- MACD
- CDNA 0.15
- GILT -0.25
- Stochastic Oscillator
- CDNA 95.64
- GILT 25.52
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.